NM_015506.3:c.507_519delAGAGGTGCCAGAT
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015506.3(MMACHC):c.507_519delAGAGGTGCCAGAT(p.Glu170CysfsTer36) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_015506.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMACHC | NM_015506.3 | c.507_519delAGAGGTGCCAGAT | p.Glu170CysfsTer36 | frameshift_variant | Exon 4 of 4 | ENST00000401061.9 | NP_056321.2 | |
MMACHC | NM_001330540.2 | c.336_348delAGAGGTGCCAGAT | p.Glu113CysfsTer36 | frameshift_variant | Exon 4 of 4 | NP_001317469.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMACHC | ENST00000401061.9 | c.507_519delAGAGGTGCCAGAT | p.Glu170CysfsTer36 | frameshift_variant | Exon 4 of 4 | 2 | NM_015506.3 | ENSP00000383840.4 | ||
MMACHC | ENST00000616135.1 | c.336_348delAGAGGTGCCAGAT | p.Glu113CysfsTer36 | frameshift_variant | Exon 4 of 5 | 2 | ENSP00000478859.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cobalamin C disease Pathogenic:5
- -
- -
This sequence change creates a premature translational stop signal (p.Glu170Cysfs*36) in the MMACHC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 113 amino acid(s) of the MMACHC protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with combined methylmalonic acidemia and hyperhomocysteinemia (PMID: 20924684). ClinVar contains an entry for this variant (Variation ID: 556017). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant disrupts a region of the MMACHC protein in which other variant(s) (p.Ile190Tyrfs*13, p.Trp203*, p.Tyr205*) have been determined to be pathogenic (PMID: 16311595, 20631720, 23954310, 27383490). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Variant summary: MMACHC c.507_519del13 (p.Glu170CysfsX36) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. p.Trp203X, p.Tyr205X). The variant was absent in 246244 control chromosomes. c.507_519del13 has been reported in the literature in individuals affected with Cobalamin C Disease (Methylmalonic Aciduria with Homocystinuria; Lerner-Ellis_2009, Wang_2010). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at